Research of the last 10 years revealed that cholesterol metabolism is involved in the pathogenesis of AD; presence of at least one apolipoprotein E (ApoE) 4 allele is a genetic risk factor for late-onset AD. 1 Plasma concentrations of cholesterol are increased in AD patients, [2] [3] [4] and cholesterol lowering drugs such as 3␤-hydroxy-3␤-methyl-glutaryl-CoA reductase inhibitors (statins) are discussed to reduce the risk of AD. 5, 6 Depletion of cholesterol inhibits production of ␤-amyloid in vitro 7 and statins reduce the levels of ␤-amyloid in vivo and in vitro. 8 Brain cholesterol is synthesized locally and is independent from nutritional intake. 9 Excess brain cholesterol derives either from increased synthesis or is due to neuronal cell death and needs to be eliminated from the brain. 10 The blood-brain barrier prevents cholesterol transport from the brain into the blood, thus another elimination pathway is necessary. Bjö rkhem et al described brain cholesterol hydroxylation catalyzed by a cytochrome P-450-dependent enzyme, cholesterol 24S-hydroxylase (CYP46), resulting in the formation of 24S-hydroxycholesterol, which is assumed to be the transport form for cholesterol across the blood-brain barrier. 11 The presence and concentration of 24S-hydroxycholesterol as one of the main cholesterol oxidation products in human brain was first established by Di Frisco and De Ruggieri. 24S-Hydroxycholesterol is the major cholesterol elimination product of the brain. More than 90% of plasma 24S-hydroxycholesterol originates from the brain; however, the exact transport mechanism for the elimination of 24S-hydroxycholesterol from brain into blood is not known yet. 13 We have shown previously, that 24S-hydroxycholesterol acts in vitro neurotoxic and that the neurotoxicity is due to the formation of free radicals. 14, 15 Serum and cerebrospinal fluid (CSF) concentrations of 24S-hydroxycholesterol are increased in AD patients during early stages of this disease compared to depressed persons and healthy controls. 16, 17 During the progress of AD serum 24S-hydroxycholesterol/cholesterol ratios decreased and were lower compared to controls. 18 High levels of neurotoxic 24S-hydroxycholesterol, especially during early stages of AD, might lead to advanced neurodegeneration and thus 24S-hydroxycholesterol is suggested to be an additional risk factor. The gene encoding CYP46 has recently been cloned by Lund et al and its mRNA is expressed primarily in neurons. 19 As genetic polymorphisms can influence gene expression and activity of the corresponding enzyme, alterations in the concentration of 24S-hydroxycholesterol in AD patients are possibly related to polymorphisms in the CYP46 gene.
We screened the 5Ј-region of the CYP46 gene; sequence analysis of exon 2 and 3 revealed no exonic sequence variations in all samples tested. As previously reported, we also found the intronic A → G transition (dbSNP:754203) 150 bp downstream of exon 3 (IVS2-150A → G). In intron 3 we saw a new C → T transition 43 bp upstream of exon 3 (IVS3+43C → T, Figure 1 ). Both variants represented single nucleotide polymorphisms (SNP); the distributions of the genotypes were in Hardy-Weinberg equilibrium. Carriers of the C allele of the IVS3+43C → T polymorphism were more frequent in AD patients compared to healthy controls ( Table 1 ). The number of G allele carriers of the IVS2-150A → G polymorphism was not different between AD patients and healthy controls (Table 1) . Logistic regression analysis revealed a significant influence of the IVS3+43C → T polymorphism (OR = 2.159; P = 0.023; 95% CI: 1.112-4.192, presence vs absence of C allele) and the presence of at least one ApoE4 allele (OR = 5.657; P Ͻ 0.001; 95% CI: 3.272-9.779) on the risk for AD. Age, sex and the IVS2-150A → G polymorphism were not significantly associated with AD (age: Wald 2 = 1.580; df = 1; P = 0.209; sex: Wald 2 = 1.011; df = 1; P = 0.315; IVS2-150A → G: Wald 2 = 0.055; df = 1; P = 0.815). The lack of a significant age effect is explained by the low variance of the sample. The allele frequencies in AD patients and controls were not influenced by presence or absence of the ApoE4 allele, ie we detected no interaction of the ApoE4 allele with the IVS3+43C → T or the IVS2-150A → G polymorphism (ApoE4/IVS3+43C → T: Wald 2 = 1.067; df = 1; P = 0.302; ApoE4/IVS2-150A → G: Wald 2 = 1.400; df = 1; P = 0.237). In accordance with our hypothesis that IVS3+43C → T polymorphism increases 24S-hydroxycholesterol/cholesterol ratio in CSF of AD patients, we found that carriers of the CC genotype had significantly higher 24S-hydroxycholesterol/ cholesterol ratios than carriers of the CT and TT genotypes (t-test: CC vs CT + TT: t = 2.41; P = 0.017, Figure 2 ). In agreement with no significant effect on the risk for AD the IVS2-150A → G polymorphism did not show an association with the 24S-hydroxycholesterol/ cholesterol ratios in CSF of AD patients (ANOVA, CSF: F = 0.812; df = 2; P = 0.450). There was no correlation between the Mini-Mental State Examination (MMSE) score and the 24S-hydroxycholesterol/cholesterol ratios in AD patients (r = −0.217; df = 47; P = 0.152).
This is the first study showing an association between a polymorphism within the CYP46 gene and AD. The IVS3+43C → T polymorphism which is reported here for the first time influenced the risk for AD in that the frequency of the C allele was higher in patients suffering from AD than in healthy controls. In the present study we also showed that the CC genotype of the IVS3+43C → T polymorphism was associated with increased 24S-hydroxycholesterol/cholesterol ratios in CSF, while the IVS2-150A → G polymorphism was neither significantly associated with the risk for AD nor with the ratio of 24S-hydroxycholesterol/cholesterol.
The relevant polymorphism is intronic and thus it is not clear how it acts on the 24S-hydroxycholesterol/cholesterol ratio. It might be speculated, that the IVS3+43C → T polymorphism influences the expression of CYP46. Reports from different intronic polymorphisms and their corresponding enzymes suggest that intronic variations can either influence the rate of transcription or the gene product by affecting splice sites; on the other hand they may be linked to variations in transcription-regulating regions. 20 The nucleotide variation observed in our study influences neither the 5Ј-donor nor the 3Ј-acceptor splice recognition motif of exons 3 and 4. Furthermore, its location seems not to interfere with branch point formation, since branch site sequences have been shown to be located in an area 6-59 bp downstream of the acceptor splice site. 21 Thus it remains unclear how the IVS3+43C → T polymorphism affects the corresponding 24S-hydroxycholesterol/ cholesterol ratio.
In conclusion, it appears that 24S-hydroxycholesterol plays a more important role in the development of AD than assumed. It was previously shown that serum and CSF levels of this oxysterol differ between AD patients and healthy subjects. 16, 18, 22 It might be speculated, that the altered oxysterol levels are attributable to variations in the CYP46 gene. We recently showed that 24S-hydroxycholesterol acts neurotoxically on human neuroblastoma cells in physiological concentrations, generating free radicals. 14, 15 It is known that oxidative stress is increased in brains of AD patients, 23, 24 and that the action of free radicals causes neuronal cell death. 25 Increased brain 24S-hydroxycholesterol/cholesterol ratios, related to polymorphism in the CYP46 gene, can exacerbate the oxidative burden and thus promote neuronal cell death. Therefore, the CYP46 locus may influence the susceptibility to develop AD.
Methods

AD patients and controls
AD patients (n = 114) were recruited from the Department of Psychiatry, University of Bonn (mean age: 71.52 ± 8.4 years; female, 63.9%). Patients were diagnosed according to DSM-IV, supported by clinical examination, detailed structured interviews, neuropsyMolecular Psychiatry chological testing, cognitive screening applying MMSE and neuroimaging studies. 26 Healthy controls (144) were recruited with the support of the local Census Bureau and the regional Board of Data Protection (Nordrhein-Westfalen, Germany) and diagnosed by structured interviews and neuropsychological testing (mean age: 68.84 ± 13.35 years; female, 52.7%). All patients and control subjects gave informed consent for participation in the study. The study protocol was approved by the Ethics Committee of the Faculty of Medicine of the University of Bonn.
DNA analysis
Leukocyte DNA was isolated with the Quiagen blood isolation kit according to the instructions of the manufacturer (Quiagen, Hilden, Germany). PCR of the region comprising exons 2 and 3 was performed using the following primers: 5Ј-gagccagtgctgtaacctcc-3Ј (forward) and 5Ј-ccattcctttctggatctttgg-3Ј (reverse) designed from the partial antisense sequence of chromosome 14 (GenBank acc. No: AL160313). The resulting 1056-bp amplification product was investigated by cycle sequencing with the ABI Prism Genetic Analyzer 310A (PE Biosystems, Weiterstadt, Germany). Sequence reactions were carried out using the PCR primers mentioned above. The ApoE genotype was studied as described by Hixson and Verner. 27 Analysis of cholesterol and 24S-hydroxycholesterol in CSF After an overnight fast CSF samples of 48 AD patients were obtained by lumbar puncture. Samples were frozen in aliquots and stored at −80°C until assay. CSF concentrations of 24S-hydroxycholesterol and cholesterol were measured by a modified sensitive method using combined gas-chromatography/mass spectrometry as described previously. 28 
Statistical analysis
The Hardy-Weinberg equilibrium was confirmed for both populations. The allele frequencies were com-pared using 2 -test. Logistic regression analysis was used to examine the simultaneous effects of polymorphism, age and ApoE4 genotype on the risk for AD. The association of polymorphism and 24S-hydroxycholesterol/cholesterol ratio in CSF was tested by ANOVA and Student's t-test. An effect of the severity of the disease, represented by the MMSE scores, on the 24S-hydroxycholesterol/cholesterol ratios was tested by Pearson's correlation test. P-values were set at two sided P Ͻ 0.05.
